首页> 外国专利> METHOD FOR PRODUCING COMPOSITIONS CONTAINING INHIBITOR OF INTIMA THICKENING BEING CAUSA OF ARTERIOSCLEROSIS

METHOD FOR PRODUCING COMPOSITIONS CONTAINING INHIBITOR OF INTIMA THICKENING BEING CAUSA OF ARTERIOSCLEROSIS

机译:生产包含动脉粥样硬化引起的内在增稠抑制剂的组合物的方法

摘要

An inhibitor of atherosclerotic intimal thickening, which contains an effective amount of a compound of the formula (I): CHEM wherein ring X is phenyl, substituted phenyl or 5- or 6-membered heterocyclic aryl; each of R1 and R2 which are independent of each other, is hydrogen, C5 PI 3/4 alkyl, C7 PI 1/2 cycloalkyl, C5 PI 7 alkoxy, n-butoxy, i-butoxy, sec-butoxy, tert-butoxy, R20R21N- (wherein each of R20 and R21 which are independent of each other, is hydrogen or C5 PI 7 alkyl), trifluoromethyl, trifluoromethoxy, difluoromethoxy, fluoro, chloro, bromo, phenyl, phenoxy, benzyloxy, hydroxy, trimethylsilyloxy, diphenyl-tert-butylsilyloxy, hydroxymethyl or -O(CH6)POR22 (wherein R22 is hydrogen or C5 PI 7 alkyl, and P is 1, 2, or 3); or R1 and R2 together form -CH=CH-CH=CH- or methylenedioxy, when they are at the o-position to each other; R3 is hydrogen, C5 PI 3/4 alkyl, C6 PI 1/4 alkenyl, C7 PI 1/2 cycloalkyl, C psi PI 1/2 cycloalkenyl or CHEM (wherein R7 is hydrogen, C5 PI 3/4 alkyl, C5 PI 3/4 alkoxy, C5 PI 7 alkylthio, chloro, bromo, fluoro, chloromethyl, trichloromethyl, trifluoromethyl, trifluoromethoxy, trichloromethoxy, difluoromethoxy, phenoxy, benzyloxy, hydroxy, trimethylsilyloxy, diphenyl-tert-butylsilyloxy or hydroxymethyl); or C5 PI 7 alkyl substituted by one CHEM (wherein R7 is as defined above) and zero, one or two C5 PI 7 alkyl; Y is -CH6-, -CH6CH6-, -CH=CH-, -CH6-CH=CH-, -CH=CH-CH6-, -C(CH7)=CH- or -CH=C(CH7)-; Z is -Q-CH6-W-CH6-CO6R12, CHEM (wherein Q is -C(O)-, -C(OR13)6- or -CH(OH)-, W is -C(O), -C(OR13)6- or -C(R11)(OH)-, R11 is hydrogen or C5 PI 7 alkyl, R12 is hydrogen, R14 (wherein R14 is alkyl of a chemically or physiologically hydrolyzable alkyl ester moiety, NHR23R24R25 (wherein each of R23, R24 and R25 is hydrogen or C5 PI 8 alkyl), sodium, potassium or 1/2 calcium), each R13 is independently primary or secondary C5 PI 1/4 alkyl, or two R13 together form -(CH6)6- or -(CH6)7-, and each of R15 and R16 which are independent of each other, is hydrogen atom or C5 PI 7 alkyl, or R15 and R16 together form -(CH6)6- or -(CH6)7-.
机译:动脉粥样硬化内膜增厚的抑制剂,其包含有效量的式(I)的化合物:其中环X为苯基,取代的苯基或5-或6-元杂环芳基;彼此独立的R 1和R 2各自为氢,C 5 PI 3/4烷基,C 7 PI 1/2环烷基,C 5 PI 7烷氧基,正丁氧基,异丁氧基,仲丁氧基,叔丁氧基,R 2 0R 2 2 1 N-(其中R 2 0和R 2 1各自独立彼此为氢或C 5 PI 7烷基),三氟甲基,三氟甲氧基,二氟甲氧基,氟,氯,溴,苯基,苯氧基,苄氧基,羟基,三甲基甲硅烷氧基,二苯基叔丁基甲硅烷氧基,羟甲基或-O (CH 6)POR 2 2(其中R 2 2为氢或C 5 PI 7烷基,且P为1、2或3);当R 1和R 2彼此位于邻位时,或R 1和R 2一起形成-CH = CH-CH = CH-或亚甲二氧基。 R 3是氢,C 5 PI 3/4烷基,C 6 PI 1/4烯基,C 7 PI 1/2环烷基,C psi PI 1/2环烯基或(其中R 7是氢,C 5 PI 3/4烷基,C 5 PI 3/4烷氧基,C 5 PI 7烷硫基,氯,溴,氟,氯甲基,三氯甲基,三氟甲基,三氟甲氧基,三氯甲氧基,二氟甲氧基,苯氧基,苄氧基,羟基,三甲基甲硅烷氧基,二苯基叔丁基甲硅烷氧基或羟甲基);或被一个(其中R7如上定义)和零个,一个或两个C 5 PI 7烷基取代的C 5 PI 7烷基;或Y为-CH 6-,-CH 6 CH 6-,-CH = CH-,-CH 6 -CH = CH-,-CH = CH-CH 6-,-C (CH 7)= CH-或-CH = C(CH 7)-; Z是-Q-CH 6 -W-CH 6 -CO 6 R 1> 2,(其中Q是-C(O)-,-C(OR <1> <3>)<6>-或-CH(OH)-,W为-C(O),-C(OR <1> <3>)<6>-或-C(R <1> <1> )(OH)-,R 1 1为氢或C 5 PI 7烷基,R 1 2为氢,R 1 4(其中R 1 4为烷基化学或生理上可水解的烷基酯部分的NHR 2 3 R 2 4R 2 5(其中R 2 3,R 2 4和R 2 5各自为氢或C 5 PI 8烷基,钠,钾或1/2钙),每个R 1 3独立地是伯或仲C 5 PI 1/4烷基,或两个R 5 1 3一起形成-(CH 6)6-或-(CH 6)7-,R 1 5和R 1 6各自独立。 R 1为氢原子或C 5 PI 7烷基,或R 1 5和R 1 6一起形成-(CH 6)6-或-(CH 6)< 7>-。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号